These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 9772047

  • 1. Clostridium difficile colitis: factors influencing treatment failure and relapse--a prospective evaluation.
    Nair S, Yadav D, Corpuz M, Pitchumoni CS.
    Am J Gastroenterol; 1998 Oct; 93(10):1873-6. PubMed ID: 9772047
    [Abstract] [Full Text] [Related]

  • 2. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.
    Musher DM, Aslam S, Logan N, Nallacheru S, Bhaila I, Borchert F, Hamill RJ.
    Clin Infect Dis; 2005 Jun 01; 40(11):1586-90. PubMed ID: 15889354
    [Abstract] [Full Text] [Related]

  • 3. The clinical spectrum of Clostridium difficile colitis in immunocompromised patients.
    Schweitzer MA, Sweiss I, Silver DL, Stellato TA.
    Am Surg; 1996 Jul 01; 62(7):603-7; discussion 607-8. PubMed ID: 8651560
    [Abstract] [Full Text] [Related]

  • 4. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN, Sethi AK, Nerandzic MM, Bobulsky GS, Jump RL, Donskey CJ.
    Clin Infect Dis; 2008 Jul 01; 47(1):56-62. PubMed ID: 18491964
    [Abstract] [Full Text] [Related]

  • 5. Risk factors for severity and relapse of pseudomembranous colitis in an elderly population.
    Moshkowitz M, Ben-Baruch E, Kline Z, Shimoni Z, Niven M, Konikoff F.
    Colorectal Dis; 2007 Feb 01; 9(2):173-7. PubMed ID: 17223943
    [Abstract] [Full Text] [Related]

  • 6. [Role of Clostridium difficile infection in the relapse of ulcerative colitis].
    Vilalta Castel E, Alcázar Montero MS, Navarro Gaspar C, Gimeno Aranguez M.
    An Med Interna; 2002 Dec 01; 19(12):637-9. PubMed ID: 12593034
    [Abstract] [Full Text] [Related]

  • 7. [Relapsing infections with Clostridium difficile].
    Visser WE, Dingemans-Dumas AM, Bac DJ.
    Ned Tijdschr Geneeskd; 2005 Oct 22; 149(43):2381-5. PubMed ID: 16277125
    [Abstract] [Full Text] [Related]

  • 8. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada.
    Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, Godin D, Bourassa C.
    Clin Infect Dis; 2005 Jun 01; 40(11):1591-7. PubMed ID: 15889355
    [Abstract] [Full Text] [Related]

  • 9. Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027.
    Pépin J, Valiquette L, Gagnon S, Routhier S, Brazeau I.
    Am J Gastroenterol; 2007 Dec 01; 102(12):2781-8. PubMed ID: 17900327
    [Abstract] [Full Text] [Related]

  • 10. Clostridium difficile colitis: an increasing hospital-acquired illness.
    Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC.
    Am J Surg; 1995 May 01; 169(5):480-3. PubMed ID: 7747823
    [Abstract] [Full Text] [Related]

  • 11. Metronidazole: an alternate therapy for antibiotic-associated colitis.
    Cherry RD, Portnoy D, Jabbari M, Daly DS, Kinnear DG, Goresky CA.
    Gastroenterology; 1982 May 01; 82(5 Pt 1):849-51. PubMed ID: 7060906
    [Abstract] [Full Text] [Related]

  • 12. Prognostic criteria in Clostridium difficile colitis.
    Ramaswamy R, Grover H, Corpuz M, Daniels P, Pitchumoni CS.
    Am J Gastroenterol; 1996 Mar 01; 91(3):460-4. PubMed ID: 8633491
    [Abstract] [Full Text] [Related]

  • 13. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease.
    McFarland LV, Elmer GW, Surawicz CM.
    Am J Gastroenterol; 2002 Jul 01; 97(7):1769-75. PubMed ID: 12135033
    [Abstract] [Full Text] [Related]

  • 14. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA, Bakkanagari SR, Moorthi KM, Davis MB.
    Clin Infect Dis; 2007 Aug 01; 45(3):302-7. PubMed ID: 17599306
    [Abstract] [Full Text] [Related]

  • 15. Symptomatic relapse after oral vancomycin therapy of antibiotic-associated pseudomembranous colitis.
    Bartlett JG, Tedesco FJ, Shull S, Lowe B, Chang T.
    Gastroenterology; 1980 Mar 01; 78(3):431-4. PubMed ID: 7053190
    [Abstract] [Full Text] [Related]

  • 16. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes.
    Johnson S.
    J Infect; 2009 Jun 01; 58(6):403-10. PubMed ID: 19394704
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of infections associated with Clostridium difficile].
    Szczesny A, Martirosian G.
    Wiad Lek; 2003 Jun 01; 56(5-6):278-82. PubMed ID: 14526488
    [Abstract] [Full Text] [Related]

  • 18. The changing face of Clostridium difficile: what treatment options remain?
    Shen EP, Surawicz CM.
    Am J Gastroenterol; 2007 Dec 01; 102(12):2789-92. PubMed ID: 18042108
    [Abstract] [Full Text] [Related]

  • 19. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea.
    Lagrotteria D, Holmes S, Smieja M, Smaill F, Lee C.
    Clin Infect Dis; 2006 Sep 01; 43(5):547-52. PubMed ID: 16886144
    [Abstract] [Full Text] [Related]

  • 20. Pseudomembraneous clostridium after autologous bone marrow transplantation.
    Kavan P, Sochor M, Nyc O, Lochmann O, Koutecky J, Skala PJ, McClain LK.
    Bone Marrow Transplant; 1998 Mar 01; 21(5):521-3. PubMed ID: 9535046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.